share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities

辉瑞 | 4：持股变动声明
SEC announcement ·  04/02 01:36
牛牛AI助手已提取核心信息
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
辉瑞公司 [PFE] 的举报人詹姆斯·史密斯于2024年3月28日执行了一项涉及辉瑞股票的交易。公告中未披露该交易的具体细节，包括行动类型、状态、所涉股票数量、股票性质、交易价格和股票总价值。也没有提供史密斯在交易后持有的股票数量。
辉瑞公司 [PFE] 的举报人詹姆斯·史密斯于2024年3月28日执行了一项涉及辉瑞股票的交易。公告中未披露该交易的具体细节，包括行动类型、状态、所涉股票数量、股票性质、交易价格和股票总价值。也没有提供史密斯在交易后持有的股票数量。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。